TSS
CUE icon

Two Sigma Securities’s Cue Biopharma CUE Stock Holding History

Two Sigma Securities’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,317
Closed -$28.4K – 1574
2025
Q3 		$28.4K Buy
+1,317
New +$30.9K ﹤0.01% 1077
2025
Q2 		– Sell
-346
Closed -$9.46K – 1600
2025
Q1 		$9.46K Buy
+346
New +$12.8K ﹤0.01% 1242

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Two Sigma Securities's CUE Position: Q4 2025 in Review

Two Sigma Securities sold out of Cue Biopharma (CUE) in Q4 2025, closing a stake of 1,317 shares — an estimated $28.4K sold.

Two Sigma Securities first reported a position in CUE in Q1 2025 and held it in 2 quarters. The position peaked at $28.4K in Q3 2025. 47 funds tracked by Wall St. Rank hold CUE as of Q4 2025.

  • Two Sigma Securities reported no remaining Cue Biopharma position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,317 Cue Biopharma shares in Q4 2025, an estimated $28.4K.
  • Two Sigma Securities first reported a position in Cue Biopharma in Q1 2025 and held it in 2 quarters.
  • Two Sigma Securities's Cue Biopharma position peaked at $28.4K in Q3 2025.
  • 47 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.